Van ECK Associates Corp Boosts Stake in Blueprint Medicines Co. (NASDAQ:BPMC)
Van ECK Associates Corp increased its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 48.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,116 shares of the biotechnology company’s stock after acquiring an additional 363 shares during the period. Van ECK Associates Corp’s holdings in Blueprint Medicines were worth $97,000 […]
Van ECK Associates Corp increased its position in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 48.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,116 shares of the biotechnology company’s stock after acquiring an additional 363 shares during the period. Van ECK Associates Corp’s holdings in Blueprint Medicines were worth $97,000 […]
